lenacapavir

Shop Support DM Logo

Investigations

Scorpio Our burning planet amabhungane Declassified UK

News & Analysis

Business Maverick Maverick Citizen Sport Newsdeck Maverick News Nelson Mandela Bay Johannesburg

Features

Opinionistas Maverick Life TGIFood Blog Podcasts Webinars Zapiro Cartoons Op-eds

Newspaper

E-edition Subscribe Delivery Queries

DM is much better if you are signed in...

Enter your email below and we will send you a mail with a link or one-time pin to login

Sign in with password
Sign in with OAuth

Get Support DM Shop Support DM

lenacapavir

Study shows six-monthly anti-HIV jab could end Aids in South Africa by 2032

South Africa, World, Maverick Citizen

Study shows six-monthly anti-HIV jab could end Aids in South Africa by 2032

by: Mia Malan

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar

Africa, South Africa, Maverick Citizen

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar

by: Ida Jooste

US embassy confirms Pepfar projects will restart — despite Trump’s aid ban in SA

Politics, South Africa, World, Maverick Citizen

US embassy confirms Pepfar projects will restart — despite Trump’s aid ban in SA

by: Mia Malan

Too little, too late — what a Pepfar waiver can’t do

South Africa, World, Maverick Citizen

Too little, too late — what a Pepfar waiver can’t do

by: Mia Malan

After the Bell: About 2024 — let me tell you the good news…

Business Maverick

After the Bell: About 2024 — let me tell you the good news…

by: Tim Cohen

Viatris launches local ARV production in South Africa: a game changer for HIV treatment accessibility

Sci-Tech, South Africa, Maverick Citizen

Viatris launches local ARV production in South Africa: a game changer for HIV treatment accessibility

by: Naledi Sikhakhane

South Africa's HIV challenge: progress towards 2030 goals requires urgent action and innovation

Op-eds

South Africa's HIV challenge: progress towards 2030 goals requires urgent action and innovation

by: Salim Abdool Karim and Nikita Devnarain for Spotlight

A call for urgent action in navigating the complex landscape of long-acting HIV medications

South Africa, Maverick Citizen

A call for urgent action in navigating the complex landscape of long-acting HIV medications

by: Francois Venter

How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir

Op-eds

How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir

by: Tian Johnson, Fatima Hassan, Asia Russell and Sangeeta Shashikant

Talks have started to get the twice-yearly anti-HIV jab registered in SA

Maverick Citizen

Talks have started to get the twice-yearly anti-HIV jab registered in SA

by: Mia Malan

Efficacy of six-monthly HIV prevention jab confirmed in second major study

South Africa, World, Maverick Citizen

Efficacy of six-monthly HIV prevention jab confirmed in second major study

by: Elri Voigt for Spotlight

Almost 40% of the world’s anti-HIV pill users live in South Africa

Maverick Citizen

Almost 40% of the world’s anti-HIV pill users live in South Africa

by: Mia Malan, Linda Pretorius and Zano Kunene